New York bills · 2025 Regular Session
New York A 5285
Relates to prescription labels for mifepristone and misoprostol
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- Karines Reyes (Democratic)
Summary
Official abstract published by the New York legislature
Provides the prescription label for mifepristone or misoprostol may include the address of the dispensing health care practice and shall include the address of the prescribing health care practice at the prescriber's request; provides that a health care prescriber shall inform a patient if such prescriber has included or has requested to include the name or address of the prescribing health care practice instead of the name of such prescriber on the prescription label when prescribing mifepristone or misoprostol.
Text versions
Roll-call votes
State vote data last updated Oct 15, 2026, 4:19 PM.
| Date | Vote | Result | Your legislators |
|---|---|---|---|
| Mar 10, 2025 Senate | Floor Vote | pass | Set your home in New York to see |
| Mar 5, 2025 House | Assembly Vote | pass | Set your home in New York to see |
Actions
- Mar 20, 2025 · House
SIGNED CHAP.108 - Mar 20, 2025 · House
DELIVERED TO GOVERNOR - Mar 10, 2025 · Senate
RETURNED TO ASSEMBLY - Mar 10, 2025 · Senate
PASSED SENATE - Mar 10, 2025 · Senate
3RD READING CAL.447 - Mar 10, 2025 · Senate
SUBSTITUTED FOR S4587 - Mar 5, 2025 · Senate
REFERRED TO RULES - Mar 5, 2025 · House
DELIVERED TO SENATE - Mar 5, 2025 · House
PASSED ASSEMBLY - Feb 25, 2025 · House
ORDERED TO THIRD READING RULES CAL.103 - Feb 25, 2025 · House
RULES REPORT CAL.103 - Feb 25, 2025 · House
REPORTED - Feb 24, 2025 · House
REPORTED REFERRED TO RULES - Feb 12, 2025 · House
REFERRED TO HIGHER EDUCATION